Impact of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention (from the PROTECT II Randomized Trial)

This publication has 23 references indexed in Scilit:

• A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention
  Circulation, 2012
• Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting
  Heart, 2012
• Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention
  Archives of internal medicine (1960), 2012
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
  JACC, 2011
• Prognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention
  Circulation: Cardiovascular Interventions, 2011
• Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
  JACC, 2009
• Universal Definition of Myocardial Infarction
  Circulation, 2007
• Clinical End Points in Coronary Stent Trials
  Circulation, 2007
• A contemporary overview of percutaneous coronary interventions
  JACC, 2002
• Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986
  Circulation, 2000